Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
- Citation:
- Br J Haematol vol 175 (2) 226-236
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Scientific Category: MYELOID NEOPLASIA
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 6
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- P50 CA140158, U10 CA180861, U10 CA077658, U10 CA180821, U10 CA101140, U10 CA180882, U24 CA196171, P30 CA016058, U10 CA180867, R35 CA197734
- Corr. Author:
- Authors:
- Bhavana Bhatnagar Ann-Kathrin Eisfeld Deedra Nicolet Krzysztof Mrózek James S. Blachly Shelley Orwick David M. Lucas Jessica Kohlschmidt William Blum Jonathan E. Kolitz Richard M. Stone Clara D. Bloomfield John C. Byrd
- Networks:
- LAPS-MA036, LAPS-OH007, NORTHWELL, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-10201, CALGB-10502, CALGB-10503, CALGB-10603, CALGB-19808, CALGB-9222, CALGB-9621, CALGB-9720
- Phases:
- 1, 1/2, 2, 3, N/A
- Keywords:
- acute myeloid leukaemia, DNA (cytosine-5)-methyltransferase 3 alpha, mutation clearance, survival, prognosis